We are pleased to share information regarding newly published review article on the role of immunotherapy in managing new onset refractory status epilepticus. The article, titled “Second-line Immunotherapy in New Onset Refractory Status Epilepticus” by Aurélie Hanin, Eyal Muscal, Lawrence J. Hirsch, was released on March 2 in the journal Epilepsia. This publication comes highly recommended by the ILAE for its insightful contributions to the field.
Categories